OPBK:NASDAQOP Bancorp Analysis
Data as of 2026-08-22 - not real-time
$15.30
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
OP Bancorp is priced at $15.30 and its moving averages line up in bullish order, the shorter sitting above the longer. Over a rolling month the price has gained 3.0%. Relative strength is 47.0 — neutral — and the MACD signal is bearish. Watch $14.89 as support and $16.83 as the nearer resistance level.
The shares look undervalued, trading on 7.8 times earnings below a sector average of 16.8. Analyst price targets sit 16.0% above the current price. Revenue is growing at 15.1% on a 29.8% profit margin. The 3.66% dividend yield looks covered by current payout levels.
The composite risk read is 6/10, putting it in elevated territory. With 30-day volatility of 27.1%, a beta of 0.50 and a maximum drawdown of 17.1%, position sizing matters here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to buy, carrying 7/10 conviction.
The shares look undervalued, trading on 7.8 times earnings below a sector average of 16.8. Analyst price targets sit 16.0% above the current price. Revenue is growing at 15.1% on a 29.8% profit margin. The 3.66% dividend yield looks covered by current payout levels.
The composite risk read is 6/10, putting it in elevated territory. With 30-day volatility of 27.1%, a beta of 0.50 and a maximum drawdown of 17.1%, position sizing matters here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to buy, carrying 7/10 conviction.
Top Market Events
LOS ANGELES AP — LOS ANGELES AP — OP Bancorp OPBK on Thursday reported net income of $8 million in its second...Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions...OP Bancorp posted $0.53 EPS, crushing the $0.445 consensus by 19%, as aggressive SBA loan sales at 8.17% premiums...
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 6/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 14.20
- MACD momentum is negative
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Short-term moving averages stacked above long-term ones
- P/E of 7.8 versus sector average of 16.8
- Trading above the 200-day average of 14.20
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- P/E of 7.8 versus sector average of 16.8
- Analyst targets imply +16.0% versus the current price
- Profit margin of 29.8% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth15.10%
Profit Margin29.81%
P/E Ratio7.8
ROE12.80%
ROA1.09%
P/B Ratio1.0
Op. Cash Flow$27.9M
Industry P/E16.8
Technical Analysis
TrendBullish
RSI47.0
Support$14.89
Resistance$16.83
MA 20$15.65
MA 50$15.13
MA 200$14.20
MACDBearish
VolumeStable
Fear & Greed Index94.41
Valuation
Fair Value$35.68
Target Price$17.75
Upside/Downside16.01%
GradeUndervalued
TypeValue
Dividend Yield3.66%
Risk Assessment
Beta0.50
Volatility27.11%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.